Relationship between Plasminogen Activity and Plasminogen Inhibitor during the Culture of Porcine Oviduct Epithelial Cells

  • Ahn, Shin-Hye (College of Animal Life Science, Kangwon National University) ;
  • Cheong, Hee-Tae (School of Veterinary Medicine, Kangwon National University) ;
  • Yang, Boo-Keun (College of Animal Life Science, Kangwon National University) ;
  • Kim, Dae-Young (Division Biological Science, Gacheon University of Medical and Science) ;
  • Park, Choon-Keun (College of Animal Life Science, Kangwon National University)
  • 발행 : 2009.12.31

초록

The present study was performed to identify changes of plasminogen activator (PA) and plasminogen activator inhibitor (PAI) in porcine oviduct epithelial cells (POECs) during the estrous cycle. POECs obtained from ovary in pre-ovulatory (Pre-Ov), early to mid-luteal stage (Early-mid L) and post-ovulatory stage (Post-Ov). For the examine of PA activity, $1{\times}10^5$ fresh cells of POECs were cultured in DMEM/Ham F-12 containing 10% FBS and 0.2% amphotericin under humidified atmosphere of 5% $CO_2$ in air and $38^{\circ}C$. The urokinase-type PA (uPA) was observed at 7 days of POECs culture. PA activity was measured with culture prolonged of 0, 3, 6, 12 and 24 h after culture of 7 days. The PA activity were high significantly (p<0.05) at 12 h of culture, but PA activity were decreased with culture periods increased. The PA activity in POECs of Post-Ov stage were higher significantly (p<0.05) than that of Early-mid L and Pre-Ov stage. When PAI-1 and PAI-2 were added during the POECs culture, the PA were observed significant low activity (p<0.05). The PA activity and protein expression were decreased by PA inhibitor. This results suggest that PAI-1 and PAI-2 have a suppressive action on change of PA activity during the estrous cycle of pigs. Specifically, this study using PA inhibitor was effect the PA activity and PAI expression in oviduct epithelial cells in pigs.

키워드

참고문헌

  1. Andreasen PA, Egelund R, Petersen HH (2000): The plasminogen activatrion system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57:25-40. Review https://doi.org/10.1007/s000180050497
  2. Bray BA, Hsu KC, Wigger HJ, LeRoy EC (1975): Association of fibrinogen and microfibrils with trophoblast basement membrane. Connective Tissue Research 3:55-71 https://doi.org/10.3109/03008207509152342
  3. Canipari R, Epifano O, Siracusa G, Salustri A (1995): Mouse oocytes inhibit plasminogen activator production by ovarian cumulus and granulosa cells. Developmental Biology 167:371-378 https://doi.org/10.1006/dbio.1995.1031
  4. Chain D, Kreizman T, Shapira H, Shaltiel S (1991): Plasmin cleavage of vitronectin: identification of the site and consequent attenuation in binding plasminogen activator inhibitor-1. FEBS Lett 285:251-256 https://doi.org/10.1016/0014-5793(91)80810-P
  5. Dano K, Andersen PA, Grondahl-Hansen J, Kristensen P, Nilsen LS, Skriver J (1985): Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139-266 https://doi.org/10.1016/S0065-230X(08)60028-7
  6. Declerck PJ, De Mol M, Alessi MC, Baudner S, Paques EP, Preissner KT, Muller-Berghaus G, Collen D (1988): Purification and characterization of a plaminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). Journal of Biological Chemistry 263:15454-15461
  7. Dudek GA, Kloczewiak M, Budzynski AZ, Latallo, ZS, Kopec M (1970): Characterisation and comparison of macromolecular end products of fibrinogen and fibrin proteolysis by plasmin. biochim. Biochim Biophys Acta 214:44-51 https://doi.org/10.1016/0005-2795(70)90068-1
  8. Ellis V, Wun TC, Behrendt N, Ronne E, Dano K (1990): Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J Biol Chem 265: 9904-9908
  9. Hart DA, Rehemtulla A (1988): Plasminogen activators and their inhibitors: regulators of extracellular proteolysis and cell function. Comparative biochemistry and physiology B Comparative Biochemistry 90:691-708 https://doi.org/10.1016/0305-0491(88)90323-9
  10. Irigoyen JP, Oz-Cao Anoves P, Montero L, Koziczak M, Nagamine Y (1999): The plasminogen activator system: Biology and regulation. Cellular and Molecular Life Science 56:104-132 https://doi.org/10.1007/PL00000615
  11. Kokolis NA (1990): Effect of orchidectomy on tissue plasminogen activator activity, plasminogen activator inhibition and plasmin inhibition. Haemostasis 20:233-240 https://doi.org/10.1159/000216133
  12. Lecander I, Roblin R, Astedt B (1984): Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitor. Br J Haematol 57:407-412 https://doi.org/10.1111/j.1365-2141.1984.tb02914.x
  13. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S (1981): Effect of plasminogen activator (urokinase), plasmin and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41:4629-4636
  14. Lippes J, Wagh PV (1993): Human oviductal fluid proteins. VI. Correlation between alpha-fetoprotein and serum levels of ovarian hormones. Fertility and Sterility 59:157-162
  15. Loskutoff DJ, Sawdey M (1989): Type 1 plasminogen activator. Progress in Hemostasis and Thrombosis 9:87-115
  16. Mastroianni L, Go KJ (1979): The Biology of the Fluids of the Female Genital Tract. Elsevier/North Holland pp 335-344
  17. Mochan E, Keler T (1984): Plasmin degradation of cartilage proteoglycan. Biophys Acta 800:312-315 https://doi.org/10.1016/0304-4165(84)90412-4
  18. Lee SL, Wei YH (1994): The involvement of extracellular proteinases and proteinase inhibitors in mammalian fertilization. Biotechnology and Applied Biochemistry 19:31-40
  19. Rekkas C, Kokolis N, Smokovitis A (1993): Breed and seasonal variation of plasminogen activator activity and plasminogen activator inhibition in spermatozoa and seminal plasma of the ram in correlation with testosterone in the blood. Andrologia 25:101-109 https://doi.org/10.1111/j.1439-0272.1993.tb02690.x
  20. Schatz F, Lockwood CJ (1993): Progestin regulation of plasminogen activator inhivitor type 1 in primary cultures of endometrial stromal and decidual cells. Journal of Clinical Endocrinology and Metabolism 77:621-625 https://doi.org/10.1210/jc.77.3.621
  21. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Fler H, Nicke F, Graeff H (1997): Clinical impact of the plasminogen activation system in tumor invasion an metastasis: Prognostic relevance and target for therapy. Thrombosis and Haemostasis 78:285-296
  22. Smokovitis A, Kouimtzis S, Koutsouris C, Kokolis N, Kouskoura T (1989): The effects of intrafollicular injection of plasmin and ε-aminocaproic acid on the ovulation in the ewe. Fibrinolysis 3:227-230 https://doi.org/10.1016/0268-9499(89)90051-9
  23. Taitzoglou IA, Chapman DA, Killian GJ (2003) : Induction of the acrosome reaction in bull spermatozoa with plasmin. Andrologia 35:112-116 https://doi.org/10.1046/j.1439-0272.2003.00541.x
  24. Taitzoglou IA, Chapman DA, Zervos IA, Killian GJ (2004): Effect of plasmin on movement characteristics of ejaculated bull spermatozoa. Theriogenology 62:553-561 https://doi.org/10.1016/j.theriogenology.2003.11.016
  25. Tsantarliotou M (1997): The effect of Glucocorticoids and Melatonin on the Activity of Specialized Proteases in Spermatozoa and Seminal Plasma of the Ram. Thessaloniki
  26. Vassalli JD, Sappino AP, Belin D (1991): The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072 https://doi.org/10.1172/JCI115405
  27. Verhage HG, Jaffe RC (1986): Regulation of estradiol and progesterone receptor concentration in cat uteri following chronic progesterone administration. Journal of Steroid Biochem 24:587-590 https://doi.org/10.1016/0022-4731(86)90124-X
  28. Zhang A, Paria BC, Davis DL (1999). Pig endometrial cells in primary culture: morphology, secretion of prostaglandins and proteins, and effects of pregnancy. J Anim Sci 69:3005-3015